Patents

US 11752172 B2: Natural killer (NK) cells expressing an antigen-specific functional T cell receptor (TCR) complex, methods for production thereof, and methods for therapeutic use thereof

Granted
2023-09-12
Filed
2018-01-04 application 16475803
Type
Utility · 16 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The invention provides modified Natural Killer (NK) cells expressing an antigen-specific functional T cell receptor (TCR) complex. These NK cells are used for T cell receptor (TCR) gene therapy in order to circumvent any risk of mispairing of the TCR a and β chains and to provide Major Histocompatibility Complex (MHC)-restricted antigen-specific cytotoxicity to the NK cells. The invention additionally provides methods for producing the modified NK cells, therapeutic compositions including the modified NK cells, and methods for using the modified NK cells in therapy of cancer, viral infections, autoimmunity, and graft versus host disease (GvHD).

Source: PVGPATDIS, file of 2026-04-10 (ipg230912.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Nova Southeastern University 26 patentsUS company or organizationFort Lauderdale, FLNova Southeastern University College or university EXACT high confidence: identical full name and state
NOVA SOUTHEASTERN UNIVERSITY INC Nonprofit FUZZY medium confidence: same name (governing-board words and legal endings aside) and state
PVGPATDIS, file of 2026-04-10
SABANCI UNIVERSITESI 47 patentsForeign company or organizationIşıklar, TRPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Tolga SutluIşıklar, TR1PVGPATDIS, file of 2026-04-10
Adil Doganay DURUFort Lauderdale, FL1PVGPATDIS, file of 2026-04-10
Batu ERMANIşıklar, TR2PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C07KPeptidesC07K14/7051PVGPATDIS, file of 2026-04-10
A61KPreparations for medical, dental or toiletry purposesA61K40/15PVGPATDIS, file of 2026-04-10
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N2740/16043PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

No recorded assignments or security interests on file for this patent.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.